GlassScriptPhysician profile
Anthony J Delfico
NPI 1275535379
$3,085.62
in general payments reported to CMS, 2019-2025
10 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $26.69 · 2022: $446 · 2023: $1,646 · 2024: $430 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604 · Travel and Lodging: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,603.91 |
| Travel and Lodging | $840.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,120.07 | 2019-2025 | Mako, Triathlon, Accolade |
| Seapearl East, INC | $809.01 | 2020-2023 | |
| Arthrex, INC. | $405.91 | 2023 | |
| Kerecis Limited | $217.55 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Depuy Synthes Sales INC. | $213.75 | 2019-2025 | Monovisc |
| Davol INC. | $161.57 | 2022-2025 | Surgiphor |
| Alphatec Spine, INC | $58.50 | 2024 | Invictus Mis |
| Smith+Nephew, INC. | $45.34 | 2025 | Pico 14 |
| Solventum Corporation | $39.82 | 2025 | Prevena |
| Bioventus LLC | $14.10 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Delfico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.